Differential Efatutazone's Impact on Mammary Neoplasia Dependent Upon Brca1 Dose
Endocrine-Related Cancer - United Kingdom
doi 10.1530/erc-18-0299
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2018
Authors
Publisher
Bioscientifica